Raju Pillai

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

Alex F. Herrera, Matthew Mei, Lawrence K. Low et al. · Journal of Clinical Oncology · 2016 · 187 citations · Full text

Medicine, Oncology, Hematologic Oncology +13

Double-hit B-cell Lymphomas With BCL6 and MYC Translocations Are Aggressive, Frequently Extranodal Lymphomas Distinct From BCL2 Double-hit B-cell Lymphomas

Raju Pillai, Malini Sathanoori, S. Branden Van Oss et al. · The American Journal of Surgical Pathology · 2013 · 172 citations

Medicine, Hematology, Pathology +15

<i>CCND1</i> mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma

Atish Mohanty, Natalie Sandoval, Manasi Das et al. · Oncotarget · 2016 · 73 citations · Full text

Medicine, Hematology, Oncology +12

MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

Haris Ali, Ibrahim Aldoss, Dongyun Yang et al. · Blood Advances · 2019 · 71 citations · Full text

Life Sciences, Hematology, Immunology +14

Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies

Raju Pillai, Urvashi Surti, Steven H. Swerdlow · Haematologica · 2013 · 65 citations · Full text

Medicine, Oncology, Pathology +17